COVID-19: EU Commission signs third contract with Pfizer-BioNTech
The European Commission today announced that It has reserved an additional 1.8 billion doses of the coronavirus vaccine developed by Pfizer-BioNTech, on behalf of all 27 EU countries, from the end of 2021 to 2023.
View the full story here: https://www.biopharma-reporter.com/Article/2021/05/20/COVID-19-EU-secures-further-supplies-from-Pfizer-BioNTech